In 2023, the corticosteroids segment held the largest uveitis treatment market share, accounting for 26.6% of total revenue, due to the well-documented anti-inflammatory activity and fast action of ...

The MarketWatch News Department was not involved in the creation of this content. Vyome's offering is a first-of-its-kind in a broader $20B potential addressable ocular inflammation market VT-1908 ...

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, ...

Credit: Thinkstock. Approximately 20% of autoimmune-uveitis cases are associated with systemic autoimmune diseases. Uveitis, the inflammation of the pigmented vascular layer of the eye, represents a ...

Please provide your email address to receive an email when new articles are posted on . Uveitis describes inflammation that exists in the uveal tract, but the disease course has such a variety of ...

NEW ORLEANS — Uveitis, a significant cause of ocular morbidity worldwide, will undergo major changes as biologic therapies enter the field, delegates heard here at the American Academy of ...

Background and aim Juvenile idiopathic arthritis-associated uveitis (JIAU) is a potentially blinding condition beginning in ...

Please provide your email address to receive an email when new articles are posted on . Complex, multifactorial and associated with at least 40 different disorders, uveitis is the fifth leading cause ...

PORTLAND, Oregon, Feb. 25, 2020 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, ...

TNF-α is a proinflammatory cytokine produced by various cells including macrophages and neutrophils and exacerbates immune diseases including uveitis. [5–9] TNF-α production in peripheral monocytes is ...

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and ...

VT-1908 eyedrop achieves the desired concentration in the anterior chamber of the eye and significantly reduces uveitis score in preclinical models (P<0.001) CAMBRIDGE, Mass., September 17, ...